These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36033764)

  • 21. Antimicrobial resistance (AMR) at the community level: An urban and rural case study from Karnataka.
    Balachandra SS; Sawant PS; Huilgol PG; Vithya T; Kumar GS; Prasad R
    J Family Med Prim Care; 2021 Mar; 10(3):1404-1411. PubMed ID: 34041186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the estimation of the global burden of antimicrobial resistant infections.
    Limmathurotsakul D; Dunachie S; Fukuda K; Feasey NA; Okeke IN; Holmes AH; Moore CE; Dolecek C; van Doorn HR; Shetty N; Lopez AD; Peacock SJ;
    Lancet Infect Dis; 2019 Nov; 19(11):e392-e398. PubMed ID: 31427174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting effects of changed antimicrobial usage on the abundance of antimicrobial resistance genes in finisher' gut microbiomes.
    Andersen VD; Aarestrup FM; Munk P; Jensen MS; de Knegt LV; Bortolaia V; Knudsen BE; Lukjancenko O; Birkegård AC; Vigre H
    Prev Vet Med; 2020 Jan; 174():104853. PubMed ID: 31783288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.
    Saeed DK; Farooqi J; Shakoor S; Hasan R
    BMC Infect Dis; 2021 Dec; 21(1):1231. PubMed ID: 34876041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy.
    Hillock NT; Merlin TL; Turnidge J; Karnon J
    Appl Health Econ Health Policy; 2022 Jul; 20(4):479-486. PubMed ID: 35368230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
    Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
    Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance.
    Ananthakrishnan A; Painter C; Teerawattananon Y
    Syst Rev; 2021 Sep; 10(1):242. PubMed ID: 34488879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid Detection of Antimicrobial Resistance in Mycoplasma genitalium by High-Resolution Melting Analysis with Unlabeled Probes.
    Li Y; Xiu L; Wang L; Zhang L; Wang F; Peng J
    Microbiol Spectr; 2022 Aug; 10(4):e0101422. PubMed ID: 35880894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing surveillance of antimicrobial resistance: Summary of the 2015 CIDSC Report.
    Amaratunga K; Tarasuk J; Tsegaye L; Archibald CP; ;
    Can Commun Dis Rep; 2016 Nov; 42(11):232-237. PubMed ID: 29769992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections.
    Serpa PH; Deng X; Abdelghany M; Crawford E; Malcolm K; Caldera S; Fung M; McGeever A; Kalantar KL; Lyden A; Ghale R; Deiss T; Neff N; Miller SA; Doernberg SB; Chiu CY; DeRisi JL; Calfee CS; Langelier CR
    Genome Med; 2022 Jul; 14(1):74. PubMed ID: 35818068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands.
    Altorf-van der Kuil W; Schoffelen AF; de Greeff SC; Thijsen SF; Alblas HJ; Notermans DW; Vlek AL; van der Sande MA; Leenstra T;
    Euro Surveill; 2017 Nov; 22(46):. PubMed ID: 29162208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated research agenda for water, sanitation and antimicrobial resistance.
    Sano D; Louise Wester A; Schmitt H; Amarasiri M; Kirby A; Medlicott K; Roda Husman AM
    J Water Health; 2020 Dec; 18(6):858-866. PubMed ID: 33328358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals.
    Zillich AJ; Sutherland JM; Wilson SJ; Diekema DJ; Ernst EJ; Vaughn TE; Doebbeling BN
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1088-95. PubMed ID: 17006817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial use and antimicrobial resistance trends in Canada: 2014.
    Ebrahim M; Gravel D; Thabet C; Abdesselam K; Paramalingam S; Hyson C
    Can Commun Dis Rep; 2016 Nov; 42(11):227-231. PubMed ID: 29769991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol.
    Naylor NR; Silva S; Kulasabanathan K; Atun R; Zhu N; Knight GM; Robotham J
    Syst Rev; 2016 Nov; 5(1):187. PubMed ID: 27821153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Road to comprehensive estimation of antimicrobial resistance (AMR) disease burden in Japan.
    Tsuzuki S; Matsunaga N; Ohmagari N
    Glob Health Med; 2020 Jun; 2(3):164-167. PubMed ID: 33330801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenges and successes of implementing a sustainable antimicrobial resistance surveillance programme in Nepal.
    Malla S; Dumre SP; Shakya G; Kansakar P; Rai B; Hossain A; Nair GB; Albert MJ; Sack D; Baker S; Rahman M;
    BMC Public Health; 2014 Mar; 14():269. PubMed ID: 24650008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for
    Sadiq ST; Mazzaferri F; Unemo M
    Sex Transm Infect; 2017 Dec; 93(S4):S65-S68. PubMed ID: 28684610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is scientific evidence enough? Using expert opinion to fill gaps in data in antimicrobial resistance research.
    Cousins M; Parmley EJ; Greer AL; Neiterman E; Lambraki IA; Graells T; Léger A; Henriksson PJG; Troell M; Wernli D; Søgaard Jørgensen P; Carson CA; Majowicz SE
    PLoS One; 2023; 18(8):e0290464. PubMed ID: 37616319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.